Moonage Media Review: Viewbix (VBIX) Targets Israel's Multi-Disciplinary Quantum Hub in Strategic Acquisition Move Toward the Quantum Future

Core Viewpoint - Viewbix Inc. is strategically acquiring Quantum X Labs to enhance its position in the quantum technology sector, targeting various applications and leveraging Israel's academic strengths in the field [1] Acquisition Details - Viewbix signed a definitive agreement to acquire 85-100% of Quantum X Labs, with completion expected within 90 days, pending due diligence and regulatory approvals [1] - The acquisition includes Quantum X Labs' expanding patent portfolio, particularly in quantum error correction [1] Financial Aspects - A private placement financing was amended in early January 2026, involving 800,000 units at approximately $1.75, raising about $1.4 million gross, with an additional potential of up to $1.68 million in warrants [1] - Majority stockholder written consent was secured on January 5, 2026, and a definitive Schedule 14C was filed with the SEC on January 15, 2026 [1] Quantum X Labs' Portfolio - Quantum X Labs is developing several key technologies: - Nuclear Quantum focuses on reactor simulation and materials science [1] - QuantumQ Security aims to protect data and infrastructure [1] - Quantum Aton Accuracy leverages quantum principles for precision applications [1] - Cliniquantum is working on drug discovery methods using quantum-enhanced techniques [1] - Quantum Transportation addresses scalability issues in quantum computing [1] - Quantum Gyro is developing technology for GPS-denied environments [1] Market Position and Ecosystem - Quantum X Labs is positioned to tap into significant near-term total addressable markets (TAMs) in navigation, precision timing, security, and nuclear simulation [1] - The company benefits from Israel's elite university ecosystem, which provides a talent edge and fosters interdisciplinary collaboration [1]